{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Talk to Your Pharmacist","title":"Testing Drug Quality & Safety with Valisure CEO, David Light","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/267756de\"></iframe>","width":"100%","height":180,"duration":2392,"description":"In this episode, we chat with David Light,  Founder & CEO, of the pharmacy and analytical lab company about drug safety and quality. High-level overview of Valisure:\r\n-- Valisure is the first ever pharmacy attached to a laboratory where every batch of medication is analyzed before being dispensed.\r\n-- Valisure’s mission is to help ensure the safety, quality, and transparency in the medications it delivers to consumers.  \r\n-- All medications at Valisure come with a certificate of analysis, similar to nutritional information on food, and are sold at no additional cost.\r\n-- Valisure currently rejects over 10% of the batches we analyze for problems related to dosage, dissolution (how a pill dissolves), and the presence of carcinogens.\r\n-- Approximately 80% of medications in the U.S. are made from materials coming from India and China\r\n-- The $2 trillion global pharma supply chain is incredibly complex and medications can touch 10-20 hands before reaching the consumer.\r\n\r\nGuest - David Light\r\n             Founder & CEO, Valisure\r\n www.valisure.com\r\n \r\nSelected media highlights:\r\nNew York Times: Zantac Products Should Not Be Sold or Used, F.D.A. Warns, Citing Cancer Danger\r\nBloomberg News: Carcinogen Found by Pharmacy in Popular U.S. Diabetes Drug\r\nWashington Post Feature Story: A tiny pharmacy is identifying big problems with common drugs, including Zantac\r\nBloomberg Businessweek 9/16/19 Cover Story: Carcinogens Have Infiltrated the Generic Drug Supply in the U.S.\r\nReuters: Online pharmacy flags possible new impurity in blood pressure drug \r\n \r\nValisure and Govzilla Drug Quality Scores Collaboration: Press Release (Jan 8, 2020)\r\n \r\nRep. DeLauro Calls for Ranitidine Ban and Reintroduces Bill: Congressional Press Release (Valisure presented at joint press conference in US Capitol Building, Jan 10, 2020)\r\nSen. Warren, Cotton, Kaine and Romney Letter on Drug Safety and Reliance on China: Congressional Press Release (Valisure data directly discussed and cited in letter,...","thumbnail_url":"https://img.transistorcdn.com/8xxOLgDhoMmY5d6Sc40bHktJGqsjbkVRV3Q6djG7yEI/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzM2NjUvMTU2NTcz/OTA3OC1hcnR3b3Jr/LmpwZw.webp","thumbnail_width":300,"thumbnail_height":300}